×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Movies UK
Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 16.67% and 20%, respectively, for the quarter ended March...
2 days ago
Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Business Wire
Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment...
24 hours ago
Syros Pharmaceuticals Sets Ambitious Timeline for Tamibarotene Regulatory Submission in MDS
Precision Medicine Online
NEW YORK – After undergoing restructuring due to limited cash flow in 2023, Syros Pharmaceuticals is laser focused on bringing its late-stage...
1 month ago
After 2 partners walk away, Syros cuts 35% of workforce and lines up new CEO
Fierce Biotech
A few weeks after a second company walked away from Syros Pharmaceuticals, the biotech is laying off 35% of staff and sharpening its focus...
7 months ago
Short Interest in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Decreases By 22.0%
MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS - Get Free Report) was the target of a significant decline in short interest during the month of...
2 days ago
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research
Syros Pharmaceuticals (SYRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming...
2 weeks ago
SYRS Stock Quote Price and Forecast
CNN
View Syros Pharmaceuticals, Inc. SYRS stock quote prices, financial information, real-time forecasts, and company news from CNN.
1 month ago
Syros stock jumps on FDA fast track tag for leukemia drug
Seeking Alpha
Shares of Syros Pharmaceuticals (NASDAQ:SYRS) traded higher on Tuesday on the news that the U.S. Food and Drug Administration (FDA) granted...
1 month ago
Syros Pharmaceuticals Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag
Yahoo Movies Canada
Syros Pharmaceuticals ( NASDAQ:SYRS ) Full Year 2022 Results Key Financial Results Revenue: US$14.9m (down 37% from FY...
2 days ago
Syros Highlights Anticipated 2024 Milestones to Deliver on the Value of Tamibarotene
Business Wire
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of...
4 months ago